Hypertension in Pregnancy

Papers
(The TQCC of Hypertension in Pregnancy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial27
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates26
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China17
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients15
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials13
Identification risk factors for perinatal complications among pregnant women with pulmonary arterial hypertension12
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk11
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review11
Correction11
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy11
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section10
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway8
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy7
Targeting oxidative stress in preeclampsia7
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio6
A nomogram for preeclampsia risk prediction in the first trimester: a nested case-control study5
Bioelectrical impedance–derived extracellular fluid expansion and perinatal outcomes in preeclampsia5
Umbilical cord-derived exosomal miR−548 is involved in driving preeclampsia pathogenesis by Inhibiting trophoblast cells invasion5
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy5
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis4
SII serves as an independent diagnostic indicator for GDM and is regulated by placental 5-HT/NF-κB signaling4
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies4
Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?3
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter3
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood3
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study3
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study3
The role of early second trimester maternal serum cadherin-11 levels in the prediction of preeclampsia3
0.25398993492126